APTEVO THERAPEUTICS INC. — Cash Flow Charts
9 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+50.4% +$21M
$-21M
Free Cash Flow↑+50.5% +$21M
$-21M
Investing Cash Flow↓-100.7% -$4M
$-29K
Financing Cash Flow↓-113.0% -$23M
$-3M
Capex↓-81.0% -$124K
$29K
Stock-Based Comp↑+12.8% +$204K
$2M
Debt Issued
$20M
Debt Repaid
$12M
D&A↓-59.7% -$1M
$901K
SBC Allocated Expense↑+12.8% +$204K
$2M